全文获取类型
| 收费全文 | 110篇 |
| 免费 | 7篇 |
| 国内免费 | 2篇 |
专业分类
| 综合类 | 6篇 |
| 化学工业 | 66篇 |
| 金属工艺 | 1篇 |
| 机械仪表 | 5篇 |
| 能源动力 | 2篇 |
| 轻工业 | 18篇 |
| 石油天然气 | 1篇 |
| 无线电 | 4篇 |
| 一般工业技术 | 10篇 |
| 冶金工业 | 3篇 |
| 原子能技术 | 1篇 |
| 自动化技术 | 2篇 |
出版年
| 2024年 | 2篇 |
| 2023年 | 1篇 |
| 2022年 | 22篇 |
| 2021年 | 19篇 |
| 2020年 | 5篇 |
| 2019年 | 3篇 |
| 2017年 | 2篇 |
| 2016年 | 10篇 |
| 2015年 | 8篇 |
| 2014年 | 5篇 |
| 2013年 | 4篇 |
| 2012年 | 5篇 |
| 2011年 | 9篇 |
| 2010年 | 3篇 |
| 2009年 | 6篇 |
| 2008年 | 4篇 |
| 2007年 | 7篇 |
| 2006年 | 1篇 |
| 2005年 | 2篇 |
| 2004年 | 1篇 |
排序方式： 共有119条查询结果，搜索用时 15 毫秒
1.
2.
Fangyu Qiao;Yang Zou;Binglin Bie;Yonggang Lv; 《Small (Weinheim an der Bergstrasse, Germany)》2024,20(8):2307062
Vascularization and innervation play irreplaceable roles in bone regeneration and bone defect repair. However, the reconstruction of blood vessels and neural networks is often neglected in material design. This study aims to design a genetically functionalized matrix (GFM) and enable it to regulate angiogenesis and neurogenesis to accelerate the process of bone defect repair. The dual small interfering RNA (siRNA)-polyvinylimide (PEI) (siRP) complexes that locally knocked down soluble vascular endothelial growth factor receptor 1 (sFlt-1) and p75 neurotrophic factor receptor (p75NTR) are prepared. The hybrid cell membrane (MM) loaded siRP is synthesized as siRNA@MMs to coat on polylactone (PCL) electrospun fibers for mimicking the natural bone matrix. The results indicates that siRNA@MMs could regulate the expression of vascular-related and neuro-related cytokines secreted by mesenchymal stem cells (MSCs). GFMs promote the expression of osteogenic differentiation through paracrine function in vitro. GFMs attenuates inflammation and promotes osseointegration by regulating the coupling of vascularization and innervation in vivo. This study uses the natural hybrid cell membrane to carry genetic material and assist in the vascularization and innervation function of two siRNA. The results present the significance of neuro-vascularized organoid bone and may provide a promising choice for the design of bone tissue engineering scaffold. 相似文献
3.
Emine Kaplanoglu Igor Kolotilin Rima Menassa Cam Donly 《International journal of molecular sciences》2022,23(7)
Plant-mediated RNA interference (RNAi) holds great promise for insect pest control, as plants can be transformed to produce double-stranded RNA (dsRNA) to selectively down-regulate insect genes essential for survival. For optimum potency, dsRNA can be produced in plant plastids, enabling the accumulation of unprocessed dsRNAs. However, the relative effectiveness of this strategy in inducing an RNAi response in insects using different feeding mechanisms is understudied. To investigate this, we first tested an in vitro-synthesized 189 bp dsRNA matching a highly conserved region of the v-ATPaseA gene from cotton mealybug (Phenacoccus solenopsis) on three insect species from two different orders that use leaf-chewing, lacerate-and-flush, or sap-sucking mechanisms to feed, and showed that the dsRNA significantly down-regulated the target gene. We then developed transplastomic Micro-tom tomato plants to produce the dsRNA in plant plastids and showed that the dsRNA is produced in leaf, flower, green fruit, red fruit, and roots, with the highest dsRNA levels found in the leaf. The plastid-produced dsRNA induced a significant gene down-regulation in insects using leaf-chewing and lacerate-and-flush feeding mechanisms, while sap-sucking insects were unaffected. Our results suggest that plastid-produced dsRNA can be used to control leaf-chewing and lacerate-and-flush feeding insects, but may not be useful for sap-sucking insects. 相似文献
4.
5.
6.
为了设计高效的siRNA（Short-interfering Ribonucleic Acid）分子、最大限度地减少siRNA分子的脱靶效应（off-target effects）,siRNA分子设计已经成为热门研究领域。siRNA分子设计主要是基于序列和能量特征,以及靶标的二级结构特征,基于这些特征设计的siRNA分子已经有了较高的抑制基因表达的效率。RNAi（RNA in-terference）在基因发现以及疾病治疗领域已有非常广泛的应用,就siRNA分子设计近年的研究进展作一综述,为今后siRNA研究提供参考。 相似文献
7.
《Food Control》2017
To test the market viability of a non-GMO topical RNAi insect control, we conducted a Willingness-To-Pay (WTP) survey in the USA, Canada, Australia, France, and Belgium to elicit whether consumers need a premium or discount for: (1) a hypothetical GMO rice variety using the Bacillus thuringiensis (Bt) gene for insect control; and (2) a hypothetical non-GMO rice variety using topical RNAi spray for insect control. The survey was designed based on a Multiple Price List (MPL) format where respondents selected their preferred insect control technology; i.e., conventional, GMO Bt, or non-GMO RNAi, at different prices. Participants' responses were analyzed using an interval regression model to generate WTP premiums and discounts for each country with control variables for demographic influences. Further, we asked consumers their Willingness-To-Consume (WTC) food produced with GM and RNAi technologies respectively and evaluated WTC differences using a McNemar matched pairs test in each country. The results from our study clearly show that: (1) consumers in the USA, Canada, Australia, and France still require a discount for rice produced with topical RNAi compared to conventionally-produced rice (p < 0.05), (2) consumers in the USA, Canada, Australia, France, and Belgium would need an additional 30–40% discount to purchase Bt rice over rice produced with topical RNAi (p < 0.05), and (3) consumers in all countries were more willing to consume rice produced with non-GM RNAi than with GM Bt technology (p < 0.05). These findings suggest consumers differentiate among biotechnology solutions and consumers may prefer topical RNAi insect control to transgenic GMO insecticides. 相似文献
8.
Meng Zheng Yuanyuan Liu Yibin Wang Dongya Zhang Yan Zou Weimin Ruan Jinlong Yin Wei Tao Jong Bae Park Bingyang Shi 《Advanced materials (Deerfield Beach, Fla.)》2019,31(37)
Small interfering RNA (siRNA) holds inherent advantages and great potential for treating refractory diseases. However, lack of suitable siRNA delivery systems that demonstrate excellent circulation stability and effective at‐site delivery ability is currently impeding siRNA therapeutic performance. Here, a polymeric siRNA nanomedicine (3I‐NM@siRNA) stabilized by triple interactions (electrostatic, hydrogen bond, and hydrophobic) is constructed. Incorporating extra hydrogen and hydrophobic interactions significantly improves the physiological stability compared to an siRNA nanomedicine analog that solely relies on the electrostatic interaction for stability. The developed 3I‐NM@siRNA nanomedicine demonstrates effective at‐site siRNA release resulting from tumoral reactive oxygen species (ROS)‐triggered sequential destabilization. Furthermore, the utility of 3I‐NM@siRNA for treating glioblastoma (GBM) by functionalizing 3I‐NM@siRNA nanomedicine with angiopep‐2 peptide is enhanced. The targeted Ang‐3I‐NM@siRNA exhibits superb blood–brain barrier penetration and potent tumor accumulation. Moreover, by cotargeting polo‐like kinase 1 and vascular endothelial growth factor receptor‐2, Ang‐3I‐NM@siRNA shows effective suppression of tumor growth and significantly improved survival time of nude mice bearing orthotopic GBM brain tumors. New siRNA nanomedicines featuring triple‐interaction stabilization together with inbuilt self‐destruct delivery ability provide a robust and potent platform for targeted GBM siRNA therapy, which may have utility for RNA interference therapy of other tumors or brain diseases. 相似文献
9.
Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1 总被引：1，自引：0，他引：1
10.
Michael B. Beverly 《Mass spectrometry reviews》2011,30(6):979-998
RNA interference (RNAi) has quickly become a well‐established laboratory tool for regulating gene expression and is currently being explored for its therapeutic potential. The design and use of double‐stranded RNA oligonucleotides as therapeutics to trigger the RNAi mechanism and a greater effort to understand the RNAi pathway itself is driving the development of analytical techniques that can characterize these oligonucleotides. Electrospray (ESI) and MALDI have been used routinely to analyze oligonucleotides and their ability to provide mass and sequence information has made them ideal for this application. Reviewed here is the work done to date on the use of ESI and MALDI for the study of RNAi oligonucleotides as well as the strategies and issues associated with siRNA analysis by mass spectrometry. While there is not a large body of literature on the specific application of mass spectrometry to RNAi, the work done in this area is a good demonstration of the range of experiments that can be conducted and the value that ESI and MALDI can provide to the RNAi field. © 2010 Wiley Periodicals, Inc., Mass Spec Rev 30:979–998, 2011 相似文献